Stephen C. Glover - 11 Jul 2025 Form 4 Insider Report for ZyVersa Therapeutics, Inc. (ZVSA)

Role
Chief Executive Officer, Director
Signature
/s/ Peter Wolfe as Attorney-in-Fact for Stephen C. Glover pursuant to Power of Attorney
Issuer symbol
ZVSA
Transactions as of
11 Jul 2025
Net transactions value
$0
Form type
4
Filing time
15 Jul 2025, 16:22:55 UTC
Previous filing
11 Jun 2025
Next filing
03 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Glover Stephen C. Chief Executive Officer, Director C/O ZYVERSA THERAPEUTICS, INC., 2200 N. COMMERCE PARKWAY, SUITE 208, WESTON /s/ Peter Wolfe as Attorney-in-Fact for Stephen C. Glover pursuant to Power of Attorney 14 Jul 2025 0001304406

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZVSA Stock Options Award $0 +136,900 $0.000000 136,900 11 Jul 2025 Common Stock 136,900 $0.5900 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on July 11, 2025, and vest and become exercisable in equal annual installments on the first three anniversaries of the grant date, subject to the Reporting Person's continued service on each such vesting date.